INTRODUCTION
The ability of pathogenic bacteria to bind to host tissues is important as it represents an early event in the establishment of an in vivo niche. In some instances, such binding is also a prerequisite for host cell invasion, where the organisms are protected from the humoral and cellular immune responses (Alrutz & Isberg, 1998; Isberg & Tran Van Nhieu, 1994; Roberts, 1990 ). An emerging theme among pathogenic micro-organisms is their ability to utilize host cell molecules during the infectious process to facilitate their binding and entry into host cells (Watarai et al., 1996) .
Campylobacter jejuni is a Gram-negative, microaerophilic bacterium, and is recognized as the most frequent cause of gastrointestinal disease in developed countries. The ability of C. jejuni to colonize the gastrointestinal tract of humans is proposed to be essential for disease (Allos & Blaser, 1995; Wassenaar & Blaser, 1999) . Fauchère et al. (1986) found that C. jejuni isolated from individuals with fever and diarrhoea exhibited greater binding to epithelial cells than strains isolated from individuals without fever and diarrhoea. Numerous studies have been done to identify and characterize C. jejuni adhesins (De Melo & Pechère, 1990; Fauchère et al., 1989; Jin et al., 2001; Kelle et al., 1998; Kervella et al., 1993; Konkel et al., 1997; McSweegan & Walker, 1986; Moser & Schröder, 1995; Moser et al., 1992 Moser et al., , 1997 Pei et al., 1998; Schröder & Moser, 1997) . Based on these studies, C. jejuni appears to synthesize a number of adhesive molecules.
Fibronectin (Fn) is a 220 kDa glycoprotein that is present at regions of cell-to-cell contact in the gastrointestinal epithelium, thereby providing a potential binding site for pathogens (Quaroni et al., 1978) . Several bacterial pathogens, including Staphylococcus aureus (Kuusela, 1978; Rydén et al., 1983) , Streptococcus pyogenes (Jaffe et al., 1996; Myhre & Kuusela, 1983) , Salmonella enteritidis (Baloda et al., 1985) , Escherichia coli (Fröman et al., 1984; Visai et al., 1991) , Neisseria gonorrhoeae (van Putten et al., 1998) , Mycobacterium avium (Schorey et al., 1996) and Treponema species (Dawson & Ellen, 1990 Thomas et al., 1985) , bind Fn. We identified a 37 kDa outer-membrane protein in C. jejuni that mediates the binding of the organism to the extracellular matrix (ECM) component Fn (Konkel et al., 1997) . The cadF (Campylobacter adhesion to Fn) gene has thus far been found to be conserved among C. jejuni and Campylobacter coli isolates . In vivo studies have suggested that the CadF protein is required for the colonization of chickens by C. jejuni (Ziprin et al., 1999) .
Published work indicates a relationship between the pericellular Fn matrix and the cytoskeleton (Gumbiner, 1996; Miyamoto et al., 1998; van der Flier & Sonnenberg, 2001) . In mammalian cells, the actin cytoskeleton is necessary for a variety of cellular processes including control of cell-to-cell and cell-to-substrate interactions. Actin nucleation occurs at membrane-associated sites called focal adhesions. Focal adhesions are the sites at which the bundles of actin filaments (stress fibres) are cross-linked with membrane-associated adhesion molecules (e.g. integrins) and extracellular molecules (Gumbiner, 1996; Sarkar, 1999) . The integrin molecules bind extracellularly to matrix components and intracellularly associate with protein complexes consisting of vinculin, talin, a-actinin, paxillin, tensin, zyxin and focal adhesion kinase (FAK) (Miyamoto et al., 1998; Tachibana et al., 1995) . The integrins are transmembrane glycoprotein receptors composed of heterodimeric ab subunits (Danen & Yamada, 2001; Hynes, 1992; van der Flier & Sonnenberg, 2001; Vuori, 1998) . The two subunits are noncovalently associated with one another (1 : 1) in the membrane. There are 18 known a subunits and 8 known b subunits (van der Flier & Sonnenberg, 2001) . Different a and b subunit combinations dictate the specificity of cell-to-cell and cell-to-ECM recognition. The a 5 b 1 integrin receptor specifically binds Fn (Hynes, 1992; Miyamoto et al., 1998) . Integrin occupancy and clustering is associated with tyrosine phosphorylation of cellular cytoplasmic proteins including FAK and paxillin, and is a means of regulating host signal transduction events leading to actin rearrangements (Miyamoto et al., 1998; Tachibana et al., 1995) . As stated earlier, certain bacterial pathogens are known to utilize host cell ECM and cytoskeleton components to their benefit. For example, N. gonorrhoeae appears to utilize a Fn-mediated uptake pathway involving integrin receptors (van Putten et al., 1998) . The binding of N. gonorrhoeae to Fn is proposed to trigger the uptake of the organism via integrin receptors by stimulating the host cell signalling pathways that are responsible for cytoskeletal rearrangement.
Because C. jejuni isolates possess a minimum of three different adhesive molecules including CadF, JlpA and PEB1 (Jin et al., 2001; Konkel et al., 1997; Pei et al., 1998) , we sought to determine the step of the infectious process in which the CadF outer-membrane protein participates. We investigated the binding properties of two C. jejuni clinical isolates, F38011 and 81-176, to the INT 407 cell line (human embryonic intestinal cells) and the participation of the INT 407 cells in C. jejuni uptake. While the host cell cytoskeletal components involved in C. jejuni F38011 uptake have not been examined previously, C. jejuni 81-176 has been reported to be internalized via a novel pathway exclusively involving microtubules (Bacon et al., 2000; Hu & Kopecko, 1999 Kopecko et al., 2001; Oelschlaeger et al., 1993) . Based on the experiments performed herein implicating microfilaments in C. jejuni uptake, additional experiments were done to determine if the host cell signalling events known to be associated with cytoskeletal rearrangement occur during C. jejuni entry. Binding of C. jejuni to immobilized ECM. Binding of C. jejuni isolates to human plasma Fn (Sigma) was assessed as previously described (Konkel et al., 1997) . Specificity of binding was determined by preincubating Fn-coated coverslips with a 1 : 50 dilution of a rabbit anti-human Fn antibody (Telios Pharmaceuticals), preincubating C. jejuni isolates with a 1 : 50 dilution of a goat anti-C. jejuni 37 kDa serum, or by the addition of 100 mg Fn ml 21 . For each coverslip, the bacteria in each of three randomly chosen fields were counted.
METHODS
Gel electrophoresis and immunoblot analysis. Bacterial whole-cell extracts (an equivalent of 0?1 OD 600 units) were solubilized in single strength electrophoresis sample buffer and incubated at 95˚C for 5 min. Proteins were separated in SDS-12?5 % PAGE minigels as previously described (Laemmli, 1970) and electrophoretically transferred to PVDF membranes (Immobilon P; Millipore). The membranes were washed three times in PBS and incubated for 18 h at 4˚C with a 1 : 500 dilution of the goat anti-C. jejuni 37 kDa serum in PBS pH 7?4/0?01 % Tween-20 containing 20 % foetal bovine serum (FBS). Bound antibodies were detected using peroxidase-conjugated rabbit anti-goat IgG (Sigma) at a 1 : 2000 dilution and 4-chloro-1-naphthol (Sigma) as the chromogenic substrate.
Bactericidal concentration of gentamicin. Assays were performed to determine the concentration of gentamicin and length of incubation time required to kill each isolate used in this study. C. jejuni isolates, C. freundii and S. typhimurium were suspended in Minimal Essential Medium (MEM) (Gibco Invitrogen) supplemented with 1 % FBS (MEM-1 % FBS) or 10 % FBS (MEM-10 % FBS) at an approximate concentration of 2610 6 c.f.u. ml
21
. Aliquots (1 ml) of the bacterial suspensions were placed in a 24-well plate and incubated at 37˚C in a humidified, 5 % CO 2 incubator for 2 h. Gentamicin (Life Technologies) was added to the media at a final concentration of 0, 100, 250, 500 and 750 mg ml
, and the suspensions again incubated as above. Following incubation (2 or 3 h), the bacterial suspensions (1 ml) were removed and bacteria pelleted by centrifugation at 6000 g for 10 min. The supernatant fluids were discarded to remove the gentamicin and bacteria resuspended in 1 ml PBS. Suspensions were serially diluted and the number of viable bacteria assessed. Each isolate was tested at least three times in triplicate. 7 c.f.u. of a bacterial suspension. Tissue culture trays were centrifuged at 600 g for 5 min, and incubated at 37˚C in a humidified, 5 % CO 2 incubator. For binding, the infected monolayers were incubated for 2 h, rinsed three times with PBS and the epithelial cells lysed with a solution of 0?1 % (v/v) Triton X-100 (Calbiochem). The suspensions were serially diluted and the number of viable, adherent bacteria determined by counting the resultant colonies on MH/ blood plates. To measure bacterial internalization, the infected monolayers were incubated for 2 h, rinsed three times with MEM-1 % FBS, and incubated for an additional 3 h in MEM-1 % FBS containing a bactericidal concentration of gentamicin. The number of internalized bacteria was determined as outlined above. Unless otherwise stated, the reported values represent the mean counts ¡ SD derived from triplicate wells. All assays in this study using cytoskeletal inhibitors were performed at a m.o.i. ranging between 50 and 500 to ensure reproducibility, and repeated a minimum of three times. Regardless of whether a m.o.i. of 50 to 1 or 500 to 1 was used, the effect of the cytoskeletal inhibitory drugs was the same. 7 c.f.u. of each isolate while maintaining indicated inhibitor concentrations. S. typhimurium was preincubated anaerobically at 37˚C for 3 h prior to infection. Binding and internalization assays were performed as outlined above. The values reported represent the percentage of adherent and internalized bacteria relative to the control (untreated sample) or the mean ¡ SD of adherent and internalized bacteria. INT 407 cell viability, following inhibitor treatment, was assessed by rinsing the INT 407 cells twice with PBS and staining the cells for 5 min with 0?5 % trypan blue. The cells were then rinsed twice with PBS and counter-stained for 5 min with 0?5 ml 0?5 % phenol red (Humason, 1979) . The INT 407 cells were visualized with an inverted microscope.
Reversibility of cytochalasin D. INT 407 cells were pretreated with cytochalasin D and infected with bacteria as described above. To asses the reversibility of cytochalasin D, the INT 407 cell monolayers were rinsed after 2 h with MEM-1 % FBS. A set of the cytochalasin D-treated cells were then incubated for an additional 2 h in MEM-1 % FBS containing cytochalasin D or in the presence of medium alone. The number of adherent and internalized bacteria was determined as outlined above.
Preparation of the polyclonal antisera. Female New Zealand White rabbits were subcutaneously injected with 100 mg of each bacterial whole-cell extract in TiterMax Gold (CytRx Corporation). A booster injection of 50 mg whole-cell extract in Freund9s incomplete adjuvant (Sigma) was given after 4 weeks. Blood was collected prior to first and second immunizations, and 2 weeks after the second immunization. Sera were stored at 220˚C.
Confocal microscopy examination of C. jejuni infected cells.
INT 407 cells (5610 4 cells) were cultured on 13 mm circular glass coverslips for 18 h at 37˚C in a humidified, 5 % CO 2 incubator. The cells were infected by the addition of 0?5 ml of a bacterial suspension (1610 6 c.f.u. per well) in MEM. Mock-infected cells were used in certain instances as a negative control. Prior to infection, cell monolayers were rinsed once with MEM. Following incubation (45 min), the cell monolayers were rinsed three times with PBS and fixed with 3?0 % glutaraldehyde or 3?0 % paraformaldehyde in 0?1 M phosphate buffer (pH 7?2). Cells were permeabilized with 0?1 % (v/v) Triton-X 100. Tubulin was stained using a 1 : 250 dilution of FITC-conjugated monoclonal antibody against tubulin (clone DM 1A; Sigma). Actin was stained using FITC-labelled phalloidin (Sigma) at a concentration of 0?4 mg ml
. Primary antibodies directed towards bacteria were used at a 1 : 250 dilution followed by a secondary goat anti-rabbit IgG-rhodamine F(Ab9) 2 fragment antibody at a 1 : 500 dilution.
Immunoprecipitation. INT 407 cells were cultured in six-well tissue culture trays as outlined above. INT 407 cell monolayers were rinsed once with MEM and inoculated with a suspension of the C. jejuni F38011 wild-type isolate and the isogenic cadF mutant (m.o.i. 100). Tissue culture trays were centrifuged and incubated as stated previously. At timepoints indicated, cell monolayers were rinsed three times with PBS and lysed by the addition of ice-cold lysis buffer (125 mM Tris/HCl pH 8?0, 137 mM NaCl, 10 % glycerol, 0?5 % sodium deoxycholate, 1 % NP-40, 2 mM EDTA, 1 mM PMSF, 1 mM Na 3 VO 4 and 1?76 Trypsin Inhibitor Units aprotonin). The insoluble and soluble fractions were separated by centrifugation at 14 000 g for 10 min at 4˚C. Immunoprecipitation was performed by adding a mouse anti-paxillin antibody (Clone 349, Transduction Labs) to the soluble fraction and incubating at 4˚C for 2 h with end-over-end mixing. Following mixing, prewashed protein G agarose beads (Gibco-BRL) were added and samples mixed for an additional 2 h at 4˚C. The precipitate was rinsed four times in ice-cold lysis buffer and once with PBS. Samples were analysed by SDS-PAGE and immunoblot analysis as outlined above. Immunoblot detection of phosphorylated paxillin was performed using a 1 : 2000 dilution of a mouse anti-phosphotyrosine antibody (PT-66; Sigma) and a 1 : 80 000 dilution of a peroxidase-conjugated rabbit antimouse IgG by enhanced chemiluminescence (Renaissance; NEN Life Science Products). Detection of the total pool of paxillin was performed using a 1 : 10 000 dilution of a mouse anti-paxillin antibody and a 1 : 80 000 dilution of a peroxidase-conjugated rabbit anti-mouse IgG.
Other analytical procedures. To determine the MIC of gentamicin sulphate, C. jejuni strains 81-176, 81116 and F38011 were cultured on MH/blood agar plates for 24 h at 37˚C under microaerophilic conditions. Bacteria were suspended in 3 ml PBS (OD 540 50?17), and 10 ml of each cell suspension was placed onto a MH/blood agar plate containing gentamicin sulphate. Gentamicin concentrations ranged from 1 mg ml 21 to 512 mg ml
. Before and after spotting the suspensions on the antibiotic containing plates, 10 ml of each cell suspension was also placed on a MH/blood agar plate without antibiotic to ensure that bacterial viability was maintained. MICs were assessed by determining the lowest concentration of gentamicin in which no growth was observed following a 24 h incubation.
To ensure that the phenotype associated with the C. jejuni CadF mutant was due specifically to the mutation of the cadF gene, a knockout was generated in Cj1477c. Cj1477c lies downstream of the cadF gene in C. jejuni F38011, and encodes a putative hydrolase (Cj1477c) (Lyngstadaas et al., 1999; Parkhill et al., 2000) . Cj1477c was disrupted by homologous recombination via a single crossover event between the putative hydrolase gene on the chromosome and an internal fragment of the hydrolase gene on a suicide vector using methods described previously (Konkel et al., 1997) . A 512 bp fragment, which is internal to the 648 bp coding region of Cj1477c, was amplified using the primers CJ1477cKOF (59-GCA CTT TAA TTG ATT CTA CTG ATG-39) and CJ1477cRTR(KO) (59-GGC CAA AGG AGT GAT ATT AGC AG-39). The resultant fragment was ligated into the pCRII cloning vector (TA Cloning System; Invitrogen) and the ligation mixture used to transform E. coli MRF. Following plasmid purification, the cloned 512 bp fragment was then excised by restriction endonuclease digestion with EcoRI, gel-purified and ligated into pBluescript SK+ (pBSKII+) containing the aphA3 gene encoding kanamycin resistance. The pBSKII+ vector was digested with EcoRI and treated with calf intestinal alkaline phosphatase prior to ligation. The resultant plasmid was introduced into C. jejuni F38011 by electroporation. Potential insertional mutants were identified by the acquisition of kanamycin resistance. Disruption of the hydrolase gene in C. jejuni F38011 was confirmed by PCR using gene specific primers.
Plasmid carriage in C. jejuni 81-176 was confirmed by the polymerase chain reaction using the tetO (forward primer, 59-TTG ACA AAT AAA GGG TTA AGG-39; reverse primer, 59-CCT TTC AAA TCT CAT TTT ATA CG-39) and virB11 (forward primer, 59-GAA CAG GAA GTG GAA AAA CTA GC-39; reverse primer, 59-TTC CGC ATT GGG CTA TAT G-39) gene specific primers, followed by sequencing of the PCR-amplified products (Bacon et al., 2000) .
RESULTS

CadF promotes the binding of C. jejuni to Fn
Previous work in our laboratory revealed that a 37 kDa outer-membrane protein, termed CadF, promoted the binding of C. jejuni F38011 to Fn (Konkel et al., 1997) . To build on this initial work, experiments were performed to determine the role of CadF using the C. jejuni clinical isolates F38011 and 81-176. Consistent with our previous work showing that CadF is conserved among C. jejuni isolates (Konkel et al., 1997 , immunoblot analysis with a goat anti-C. jejuni CadF serum revealed a 37 kDa reactive band in the whole cell lysates of both C. jejuni F38011 and 81-176 clinical isolates. A band corresponding to the 37 kDa CadF protein was not detected in the lysate of a C. jejuni F38011 cadF mutant (Fig. 1) . The C. jejuni 81-176 wild-type isolate was also found to bind to Fn-coated coverslips (Table 1) . The binding to Fn by both C. jejuni F38011 and 81-176 was judged to be specific because it was significantly reduced by an antiFn serum, an anti-CadF serum and the addition of exogenous Fn (Table 1 ). The C. jejuni cadF mutant bound to Fn at levels less than 10 % of the C. jejuni F38011 and 81-176 clinical isolates. Additionally, no difference was noted in the binding of the C. jejuni cadF mutant to Fn-coated coverslips when compared to the BSA-coated coverslips. Collectively, these data suggest that CadF is the primary Fn-binding constituent in C. jejuni F38011 and 81-176. Bacterial whole-cell extracts (25 mg per lane) were separated in 12?5 % SDS-PAGE gels, transferred to PVDF membranes and reacted with a goat anti-37 kDa serum. A 37 kDa band (arrow) corresponding to the CadF protein was detected in the wholecell extracts of both the C. jejuni F38011 and 81-176 clinical isolates. The faster migrating band, with an approximate mass of 32 kDa, represents the heat-modifiable form of the protein characteristic of outer-membrane proteins (Bolla et al., 1995) . Lanes: 1, C. jejuni 81-176 (biotype I, Lior serotype 5); 2, C. jejuni F38011 (biotype I, Lior serotype 90); 3, C. jejuni F38011 cadF mutant. Assays were performed as outlined in Methods. For each sample, the bacteria in each of three randomly chosen fields were counted. Results are presented as the mean ¡ standard deviation of triplicate determinations for each sample relative to the binding of the C. jejuni wild-type isolates to Fn (C. jejuni F38011 5 479 ¡ 15 c.f.u. and C. jejuni 81-176 5 754 ¡ 37 c.f.u.). Note: the C. jejuni cadF mutant bound to Fn and BSA at 9 ¡ 4 % and 7 ¡ 3 % compared to the C. jejuni F38011 wild-type isolate, respectively.
Substrate (40 mg)
Inhibitor Bound bacteria (%) 
C. jejuni internalization involves actin cytoskeletal reorganization
Previous studies with C. jejuni 81-176 have suggested that this isolate is internalized via a unique pathway requiring only microtubules (Oelschlaeger et al., 1993) . Because C. jejuni 81-176 binds to Fn, we re-examined the role of microfilaments in C. jejuni 81-176 binding and internalization in the presence of microfilament inhibitors. Cytochalasin D serves as an actin-capping compound that binds to the barbed end of actin filaments, thereby shifting the polymerization-depolymerization equilibrium leading to depolymerization of microfilaments (Cooper, 1987) . S. typhimurium and C. freundii were used as controls (Biswas et al., 2000; Oelschlaeger et al., 1993) . Prior to performing the assays, preliminary experiments were conducted to ensure that cytochalasin D, at the concentrations used here, had no effect on INT 407 cell viability. In addition, preliminary experiments were conducted with each bacterial isolate to ensure that a bactericidal concentration of gentamicin was used in the invasion assay. In contrast to previous reports (Bacon et al., 2000; Hu & Kopecko, 1999; Oelschlaeger et al., 1993) , it was found necessary to treat C. jejuni 81-176 with a concentration of 500 mg gentamicin ml 21 for 3 h to kill the organism. A 2 h treatment of C. jejuni 81-176 (range 1?7-3?2610 6 c.f.u.) with 100 mg gentamicin ml 21 resulted in the recovery of 4?8610 4 -2?9610 5 c.f.u. (n54 individual experiments). The bactericidal activity of gentamicin was dependent on concentration and time of exposure while independent of the percentage of FBS in the medium (1 % or 10 %).
The effects of cytochalasin D on the C. jejuni F38011 and 81-176 clinical isolates, S. typhimurium, and C. freundii are shown in Table 3 . Cytochalasin D resulted in a dosedependent increase in binding and a dose-dependent decrease in internalization of both C. jejuni F38011 and 81-176 to INT 407 cells regardless of the m.o.i. used in an individual experiment. Consistent with previous reports (Bacon et al., 2000; Biswas et al., 2000; Hu & Kopecko, 1999 Oelschlaeger et al., 1993) , cytochalasin D also significantly inhibited the internalization of S. typhimurium and C. freundii by INT 407 cells. Confocal microscopy examination of the infected INT 407 cells did not reveal convincing evidence for the interaction of C. jejuni with cellular microfilaments. However, microfilament supported structures were observed in contact with C. jejuni 81-176 (Fig. 2) . Also noted was the expected interaction of S. typhimurium with a cellular structure supported by microfilaments.
To further investigate the role of microfilaments in C. jejuni internalization, assays were performed with mycalolide B. Mycalolide B severs microfilaments (F-actin), causing them to depolymerize, and sequesters G-actin, which inhibits microfilament polymerization (Saito et al., 1994 Wada et al., 1998) . While mycalolide B was found to significantly inhibit the internalization of C. jejuni and S. typhimurium (Table 4) , the drug had no effect on the viability of the INT 407 cells as judged by staining with trypan blue (data not shown). These data also suggest that the uptake of C. jejuni F38011, as well as 81-176, utilize microfilaments. Our finding of the requirement for actin rearrangement in S. typhimurium internalization is consistent with that of previous reports (Finlay et al., 1991; Francis et al., 1992 Francis et al., , 1993 ).
The effect of cytochalasin D on C. jejuni internalization is reversible
Because treatment of the INT 407 cells with cytochalasin D inhibited the uptake of each organism tested (C. jejuni F38011, C. jejuni 81-176, S. typhimurium and C. freundii), we questioned whether a small number of the INT 407 cells were being removed from the plastic substrate during the rinsing steps. If cells were detaching from the plastic substrate during either the drug-treatment step or the rinses, it could contribute to the decrease noted in internalized organisms. Thus, an assay was performed to examine the (Table 5 ). In addition, the increase in adherent bacteria caused by the drug treatment resulted in an increase in internalized organisms following the drug's removal from the assay medium, indicating that the adherent bacteria are capable of becoming internalized.
C. jejuni internalization is sensitive to microtubule inhibitors Binding and internalization assays were also performed with the C. jejuni F38011 and 81-176 clinical isolates, S. typhimurium and C. freundii in the presence of the microtubule inhibitor nocodazole (Table 6 ). Nocodazole binds b-tubulin, preventing tubulin polymerization, as well as enhances GTPase activity (Mejillano et al., 1996) . Nocodazole had no effect on the binding of the C. jejuni isolates to the INT 407 cells, but did significantly inhibit the uptake of both isolates by the INT 407 cells in a dosedependent fashion. While the internalization of C. freundii was also significantly inhibited by nocodazole, the drug had no effect on S. typhimurium internalization. A clear association of C. jejuni with microtubules was not observed by confocal microscopy examination of the infected INT 407 cells (Fig. 3) .
Others have suggested that C. jejuni can be internalized via two distinct uptake pathways where microtubules and microfilaments act exclusively (Hu & Kopecko, 1999; Kopecko et al., 2001; Oelschlaeger et al., 1993) . Because the uptake of the C. jejuni isolates tested was found to be sensitive to both microfilament and microtubule depolymerizing agents, assays were performed to determine the combined effects of these drugs on C. jejuni internalization (Table 7) . When the drugs were used in combination, the number of C. jejuni bound to the INT 407 cells was comparable to that obtained when only cytochalasin D was used. Significant differences were not observed in the number of C. jejuni internalized by the INT 407 cells in the presence of either cytochalasin D or nocodazole alone versus when the drugs were used in combination with one another. As the combination of these two drugs on C. jejuni internalization was not additive, the data suggest that 45 ¡ 8* 142 ¡ 8* *The value was significantly different (P , 0?01) from that obtained using the wild-type isolate in the absence of the inhibitor. Significance between samples was determined using Student9s t test following logarithmic (log 10 ) transformation of the data.
microfilaments and microtubules act in concert to facilitate C. jejuni uptake (Table 7) .
Maximal C. jejuni entry is accompanied by the tyrosine phosphorylation of paxillin As the data indicate that C. jejuni uptake involves cytoskeletal rearrangement, it is likely that the uptake of the organism is accompanied by cytoskeletal signal transduction events. Therefore, experiments were performed to examine the levels of tyrosine phosphorylated paxillin in INT 407 cells immediately prior to and following inoculation with C. jejuni. An increased level of phosphorylated paxillin is an indicator of integrin stimulation (Watarai et al., 1996) . Integrin molecules bind extracellularly to matrix components (e.g. Fn) and intracellularly associate with protein complexes that ultimately are linked to microfilaments. Here, the INT 407 cells were infected with the C. jejuni F38011 isolate at a m.o.i. of 100 to 1 and incubated for varying lengths of time, ranging between 15 and 60 min. Following incubation, the focal adhesion-associated protein paxillin was immunoprecipitated and subjected to SDS-PAGE coupled with immunoblot analysis using an antiphosphotyrosine antibody. Infection of the INT 407 cells with the C. jejuni F38011 wild-type isolate led to an increase in the level of tyrosine phosphorylated paxillin at 30 and 45 min post-infection (Fig. 4 ). An increase in the level of phosphorylated paxillin was not observed in INT 407 cells infected with the C. jejuni cadF mutant until the m.o.i. was increased 20-fold beyond that of the wild-type isolate, after which the pattern of phosphorylated paxillin mirrored that observed for the wild-type isolate (data not shown). Consistent with paxillin phosphorylation, co-localization was observed between C. jejuni and host cell-tyrosine phosphorylated proteins by confocal microscopy (data not shown).
DISCUSSION
Binding of C. jejuni to epithelial cells is mediated by several outer-membrane proteins including JlpA, PEB1 and CadF (Jin et al., 2001; Konkel et al., 1997; Pei et al., 1998) . Although it is difficult to assess the contribution of each adhesin in the adherence of C. jejuni to host cells given variations in assay protocols, knockouts have been generated in the genes encoding the JlpA, PEB1 and CadF adhesins, and the phenotypes examined. A C. jejuni jlpA knockout is reduced 19 % in adherence to HEp-2 cells (Jin et al., 2001) . A C. jejuni peb1 knockout is reduced 10-99 %, depending on the initial inoculum, in adherence to HeLa cells (Pei et al., 1998) . A C. jejuni cadF knockout is reduced 50-90 %, depending on the initial inoculum, in adherence to INT 407 cells. The biological significance of the CadF adhesin has also been demonstrated in vivo. Ziprin et al. (1999) reported that a C. jejuni F38011 cadF mutant is unable to colonize the intestinal tract of Leghorn chickens (n560), thus providing evidence that the 37 kDa outermembrane protein plays an in vivo role in mediating the organism's binding to the intestinal epithelium. We undertook this study to more closely examine the role of CadF in C. jejuni-host cell interactions. Based on the results presented here, CadF appears to promote the binding of C. jejuni to Fn, thereby stimulating the host cell signalling events associated with bacterial uptake.
Two C. jejuni clinical isolates, F38011 (Lior serotype 90) and 81-176 (Lior serotype 5), were used in this study. The (Schlaepfer et al., 1999) , was reversible. Finally, treatment of the INT 407 cells with mycalolide B also inhibited C. jejuni uptake. Mycalolide B severs microfilaments and sequesters G-actin. The sequestering of G-actin inhibits microfilament polymerization. Consistent with the notion that C. jejuni uptake requires the stimulation of host cell signalling molecules, the amount of phosphorylated paxillin significantly increased 30 min after C. jejuni infection. The amount of phosphorylated paxillin returned to a level equivalent to that of a non-infected control at the 1 h time point. The increase in phosphorylated paxillin slightly preceeded and was concomitant with a sharp rise in the number of C. jejuni internalized, which occurs 30-60 min post-infection (Konkel et al., 1993) .
The inhibitory effect of microtubule-depolymerizing agents on the entry of C. jejuni strain 81-176 has been noted previously (Bacon et al., 2000; Hu & Kopecko, 1999 Kopecko et al., 2001; Oelschlaeger et al., 1993) . Based on this effect, the proposal has been put forth that C. jejuni are internalized via two pathways, one involving microtubules 53 ¡ 3* 54 ¡ 4* 44 ¡ 3* *The value was significantly different (P , 0?01) from that obtained using the wild-type isolate in the absence of the inhibitor. Significance between samples was determined using Student9s t test following logarithmic (log 10 ) transformation of the data. exclusively (considered a high efficiency uptake pathway) and the other involving microfilaments (considered a low efficiency uptake pathway) . While we noted a decrease in the invasiveness of C. jejuni 81-176 with a microtubule inhibitor, a decrease was also noted in the number of intracellular bacteria with this organism in the presence of microfilament inhibitors. The discrepancy between our results and those reported earlier is most likely due to differences in assay protocols. More specifically, in previous work, a 2 h incubation with 100 mg gentamicin ml 21 was used to kill the extracellular bacteria. In our hands, treatment of C. jejuni 81-176 with 100 mg gentamicin ml 21 for 2 h typically resulted in the recovery of 3-12 % of the bacteria in the original suspension (n54 individual experiments). Thus, even though C. jejuni 81-176 is gentamicin-sensitive (e.g. MIC of 4 mg ml 21 ), it was found necessary to increase both the time of exposure and the concentration of the antibiotic to ensure bacterial death. The protocol used by others to determine the bactericidal concentration of gentamicin was not reported (Bacon et al., 2000; Hu & Kopecko, 1999 Oelschlaeger et al., 1993) . Also noteworthy is that an increase has been noted in the number of C. jejuni 81-176 internalized in the presence of cytochalasin D (Hu & Kopecko, 1999 Oelschlaeger et al., 1993) . One reason for the increase in C. jejuni 81-176 uptake noted by others with cytochalasin D may be due to an increase in the number of organisms bound to the host cells. Increasing the number of cell-associated bacteria while not using a bactericidal concentration of antibiotic would mask any effect of cytochalasin D on C. jejuni uptake. While this explanation seems possible, we do not know the number of cell-associated (adherent) bacteria in earlier studies in which the effect of cytochalasin D on C. jejuni 81-176 uptake was examined as it was not reported. Regardless, a sublethal concentration of gentamicin would not alter the net result of an internalization assay unless there was a significant increase or decrease in the number of adherent bacteria in the test sample versus the control. To the best of our knowledge, C. jejuni 81-176 is the only isolate to date that has been reported to be internalized exclusively via a microtubule-dependent pathway (Kopecko et al., 2001; Oelschlaeger et al., 1993) . Using 250 mg gentamicin ml 21 for 3 h to kill the extracellular bacteria, Biswas et al. (2000) observed a reduction in entry with both microfilament and microtubule inhibitors with every C. jejuni clinical isolate tested (n59). Biswas et al. (2000) concluded that the most invasive isolates examined in their study utilized microfilaments. Based on the data currently available, the most reasonable conclusion is that C. jejuni uptake involves cooperation of both microfilaments and microtubules. More specifically, uptake of C. jejuni 81-176 and F38011 by INT 407 cells was reduced from 56 to 66 %, respectively, in the presence of nocodazole and cytochalasin D relative to the untreated control (Table 7) . These results are consistent with those reported elsewhere, even though the experimental protocols vary (Biswas et al., 2000; Oelschlaeger et al., 1993) . What is unclear is why in the presence of both inhibitors a significant number of C. jejuni are still internalized. In comparison, Salmonella invasion was reduced by greater than 99 % by cytochalasin D compared to untreated INT 407 cells. Comparable results for Salmonella have been reported by others (Bacon et al., 2000; Biswas et al., 2000; Hu & Kopecko, 1999 Oelschlaeger et al., 1993) .
The mechanism by which treatment of cells with microtubule inhibitors causes a reduction in C. jejuni-cell uptake is not known. However, it has been reported that microtubules regulate the turnover of focal adhesion contacts and modulate a cell9s adhesive strength to the ECM (Ballestrem et al., 2000) . In fact, treatment of cells with microtubule inhibitors leads to an increase in a cell9s adherence to the ECM (Ballestrem et al., 2000; Sastry & Burridge, 2000) . Thus, the effect of a microtubule inhibitor on C. jejuni-cell uptake could be indirect, as the turnover of the focal adhesion sites is retarded. Alternatively, following initial microfilament-dependent uptake at the level of the plasma membrane, microtubules may be required for subsequent trafficking of the endosome to the interior of the cell as has been proposed for C. freundii (Badger et al., Fig. 4 . Binding of C. jejuni to INT 407 cells induces phosphorylation of the 68 kDa focal adhesion-associated protein paxillin. The C. jejuni-infected INT 407 cells were lysed and samples immunoprecipitated using an antipaxillin antibody. The precipitated proteins were separated in 10 % polyacrylamide gels and proteins transferred to PVDF membranes. Immunoblots were reacted with an anti-phosphotyrosine antibody (aPT-66) and an anti-paxillin antibody as described in Methods.
1999). Regardless, there is clearly functional cooperation between host cytoskeletal elements (Ballestrem et al., 2000; Goode et al., 2000; Sastry & Burridge, 2000) . Because the effects of cytochalasin D and nocodazole on C. jejuni uptake were not additive when used together, it appears most likely that the C. jejuni isolates tested here utilize microfilaments and microtubules together.
C. jejuni strain 81-176 has recently been reported to harbour two plasmids, one of which harbours the tetracycline resistance gene (tetO) and the other harbouring a gene termed virB11 (Bacon et al., 2000) . Moreover, in a recent review by Kopecko et al. (2001) , the authors suggested a possible correlation between the plasmid-borne genes and the microtubule-dependent uptake pathway. To ensure that the strain of C. jejuni 81-176 used in this study harboured both plasmids, the isolate was subjected to PCR using tetO and virB11 gene-specific primers. The identity of the amplified products was subsequently confirmed upon sequencing of the PCR-amplified products (not shown). Wooldridge et al. (1996) previously reported that C. jejuni uptake is reduced in the presence of protein tyrosine phosphorylation inhibitors. We chose to examine whether paxillin was phosphorylated upon infection of INT 407 cells with C. jejuni because protein tyrosine phosphorylation is one of the earliest events upon integrin stimulation (Clark & Brugge, 1995) . Consistent with the idea that the binding of C. jejuni leads to integrin stimulation, an increase in phosphorylated paxillin was observed 30-45 min after C. jejuni F38011 infection. Noteworthy is that the increase in phosphorylated paxillin occurs just prior to and concomitant with an increase in C. jejuni internalization (Konkel et al., 1993) . In contrast to the C. jejuni wild-type isolate, an increase was not observed in phosphorylated paxillin over the course of the assay with cells inoculated with the C. jejuni cadF mutant at a m.o.i. of 100 to 1 (Fig. 4) . However, upon infection of the INT 407 cells with the C. jejuni cadF mutant at a m.o.i. of greater than 2000 to 1, the pattern of phosphorylated paxillin in cells inoculated with the C. jejuni cadF mutant mirrored that obtained with the C. jejuni wild-type isolate. A possible explanation for this finding is that C. jejuni adherence is multifactorial, and that several adhesins simultaneously function to promote host cell binding, after which cell signalling events are stimulated. Thus, the CadF protein does not appear to be required to induce host cell signalling events, but appears to promote signalling events by facilitating the organism9s binding to appropriate host cells receptors. Noteworthy is that Watarai et al. (1996) observed an increase in the tyrosine phosphorylation of FAK and paxillin 20-30 min after infection of Chinese hamster ovary cells with Shigella flexneri.
In summary, the data suggest that CadF promotes C. jejunihost cell interactions. Consistent with the notion that bacterial uptake requires host cell signalling, an increase in tyrosine phosphorylated paxillin was observed upon infection of INT 407 cells with C. jejuni. Tyrosine phosphorylation of FAK and paxillin is a means of regulating host signal transduction events leading to actin rearrangement (Miyamoto et al., 1998; Tachibana et al., 1995) . Because paxillin is an integral component of focal adhesions, as are ECM components including Fn, we speculate that CadF is responsible for promoting the initial interaction of C. jejuni with the appropriate host cell receptors involved in uptake. Future studies will be directed toward the identification and biochemical characterization of the CadF Fn-binding domain(s).
